CN Patent

CN101365432B — 二肽基肽酶-4抑制剂与二甲双胍的组合的药物组合物

Assigned to Merck Sharp and Dohme BV · Expires 2011-06-22 · 15y expired

What this patent protects

公开了含有二肽基肽酶-4抑制剂和二甲双胍的固定剂量组合的药物组合物，制备所述药物组合物的方法和使用所述药物组合物治疗2型糖尿病的方法。

USPTO Abstract

公开了含有二肽基肽酶-4抑制剂和二甲双胍的固定剂量组合的药物组合物，制备所述药物组合物的方法和使用所述药物组合物治疗2型糖尿病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101365432B
Jurisdiction
CN
Classification
—
Expires
2011-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.